These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17329334)

  • 1. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection.
    MacNeil A; Sarr AD; Sankalé JL; Meloni ST; Mboup S; Kanki P
    J Virol; 2007 May; 81(10):5325-30. PubMed ID: 17329334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection.
    Berry N; Ariyoshi K; Jaffar S; Sabally S; Corrah T; Tedder R; Whittle H
    J Hum Virol; 1998; 1(7):457-68. PubMed ID: 10195267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa.
    Gottlieb GS; Sow PS; Hawes SE; Ndoye I; Redman M; Coll-Seck AM; Faye-Niang MA; Diop A; Kuypers JM; Critchlow CW; Respess R; Mullins JI; Kiviat NB
    J Infect Dis; 2002 Apr; 185(7):905-14. PubMed ID: 11920314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo.
    Popper SJ; Sarr AD; Guèye-Ndiaye A; Mboup S; Essex ME; Kanki PJ
    J Virol; 2000 Feb; 74(3):1554-7. PubMed ID: 10627569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in proviral DNA load between HIV-1- and HIV-2-infected patients.
    Gueudin M; Damond F; Braun J; Taïeb A; Lemée V; Plantier JC; Chêne G; Matheron S; Brun-Vézinet F; Simon F
    AIDS; 2008 Jan; 22(2):211-5. PubMed ID: 18097223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 DNA burden in peripheral blood CD4+ cells influences disease progression, antiretroviral efficacy, and CD4+ T-cell restoration.
    Russell RR; Bowmer MI; Nguyen C; Grant MD
    Viral Immunol; 2001; 14(4):379-89. PubMed ID: 11792067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections.
    Sarr AD; Popper S; Thior I; Hamel DJ; Sankalé JL; Siby T; Marlink R; Essex M; Mboup S; Kanki P
    J Hum Virol; 1999; 2(1):45-51. PubMed ID: 10200599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
    Re MC; Vitone F; Biagetti C; Schiavone P; Alessandrini F; Bon I; de Crignis E; Gibellini D
    Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic composition of replication competent clonal HIV-1 variants isolated from peripheral blood mononuclear cells (PBMC), HIV-1 proviral DNA from PBMC and HIV-1 RNA in serum in the course of HIV-1 infection.
    Edo-Matas D; van Gils MJ; Bowles EJ; Navis M; Rachinger A; Boeser-Nunnink B; Stewart-Jones GB; Kootstra NA; van 't Wout AB; Schuitemaker H
    Virology; 2010 Sep; 405(2):492-504. PubMed ID: 20638697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2.
    Popper SJ; Sarr AD; Travers KU; Guèye-Ndiaye A; Mboup S; Essex ME; Kanki PJ
    J Infect Dis; 1999 Oct; 180(4):1116-21. PubMed ID: 10479138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay.
    Gomes P; Taveira NC; Pereira JM; Antunes F; Ferreira MO; Lourenço MH
    J Clin Microbiol; 1999 Feb; 37(2):453-6. PubMed ID: 9889242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
    Carr JM; Cheney KM; Coolen C; Davis A; Shaw D; Ferguson W; Chang G; Higgins G; Burrell C; Li P
    J Clin Microbiol; 2007 Apr; 45(4):1288-97. PubMed ID: 17314225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.
    Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM
    N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
    Min J; Katzenstein DA
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission.
    Gottlieb GS; Hawes SE; Agne HD; Stern JE; Critchlow CW; Kiviat NB; Sow PS
    AIDS; 2006 Apr; 20(6):895-900. PubMed ID: 16549974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.
    Zheng NN; Kiviat NB; Sow PS; Hawes SE; Wilson A; Diallo-Agne H; Critchlow CW; Gottlieb GS; Musey L; McElrath MJ
    J Virol; 2004 Dec; 78(24):13934-42. PubMed ID: 15564501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
    Gibellini D; Vitone F; Schiavone P; Ponti C; La Placa M; Re MC
    J Clin Virol; 2004 Apr; 29(4):282-9. PubMed ID: 15018857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy.
    Bon I; Turriziani O; Musumeci G; Clò A; Montagna C; Morini S; Calza L; Gibellini D; Antonelli G; Re MC
    J Med Virol; 2015 Feb; 87(2):315-22. PubMed ID: 25138591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term intrapatient viral evolution during HIV-2 infection.
    MacNeil A; Sankale JL; Meloni ST; Sarr AD; Mboup S; Kanki P
    J Infect Dis; 2007 Mar; 195(5):726-33. PubMed ID: 17262716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART.
    Chew CB; Potter SJ; Wang B; Wang YM; Shaw CO; Dwyer DE; Saksena NK
    J Clin Virol; 2005 Jul; 33(3):206-16. PubMed ID: 15911442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.